Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iscartrelvir in Mild to Moderate COVID-19
NCT06197217Phase 3Completed
- Sponsor
- Westlake Pharmaceuticals (Hangzhou) Co., Ltd.
- Start
- Jun 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of iscartrelvir in coronavirus disease 2019 (COVID-19), sponsored by Westlake Pharmaceuticals (Hangzhou) Co., Ltd.. Started Jun 2023; status: completed.
02
Drugs
iscartrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT06197217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06197217.